Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung CancerBairavi Shankar, Jarushka Naidoo, David S. Ettinger et al.|JAMA Oncology|2020Cited by 498
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Biagio Ricciuti et al.|Cancer Immunology Immunotherapy|2020Cited by 97
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Biagio Ricciuti et al.|Cancer Immunology Immunotherapy|2020Cited by 3